Promoter methylation of Wnt-antagonists in polypoid and nonpolypoid colorectal adenomas
Authors:
- Quirinus Jm VoorhamQVQuirinus Jm Voorham
- Jerry JanssenJJJerry Janssen
- Marianne TijssenMTMarianne Tijssen
- Suzanne SnellenbergSSSuzanne Snellenberg
- Sandra MongeraSMSandra Mongera
- Nicole Ct van GriekenNGNicole Ct van Grieken
- Heike GrabschHGHeike Grabsch
- Martin KlimentMKMartin Kliment
- Bjorn J RembackenBRBjorn J Rembacken
- Chris Jj MulderCMChris Jj Mulder
- Manon van EngelandMEManon van Engeland
- Gerrit A MeijerGMGerrit A Meijer
Open Access
- 19 December 2013
- journal article
- Published by Springer Nature in BMC Cancer
- Vol. 13 (1) , 603
Abstract
Background: Nonpolypoid adenomas are a subgroup of colorectal adenomas that have been associated with a more aggressive clinical behaviour compared to their polypoid counterparts. A substantial proportion of nonpolypoid and polypoid adenomas lack APC mutations, APC methylation or chromosomal loss of the APC locus on chromosome 5q, suggesting the involvement of other Wnt-pathway genes. The present study investigated promoter methylation of several Wnt-pathway antagonists in both nonpolypoid and polypoid adenomas. Methods: Quantitative methylation-specific PCR (qMSP) was used to evaluate methylation of four Wnt-antagonists, SFRP2, WIF-1, DKK3 and SOX17 in 18 normal colorectal mucosa samples, 9 colorectal cancer cell lines, 18 carcinomas, 44 nonpolypoid and 44 polypoid adenomas. Results were integrated with previously obtained data on APC mutation, methylation and chromosome 5q status from the same samples. Results: Increased methylation of all genes was found in the majority of cell lines, adenomas and carcinomas compared to normal controls. WIF-1 and DKK3 showed a significantly lower level of methylation in nonpolypoid compared to polypoid adenomas (p < 0.01). Combining both adenoma types, a positive trend between APC mutation and both WIF-1 and DKK3 methylation was observed (p < 0.05). Conclusions: Methylation of Wnt-pathway antagonists represents an additional mechanism of constitutive Wnt-pathway activation in colorectal adenomas. Current results further substantiate the existence of partially alternative Wnt-pathway disruption mechanisms in nonpolypoid compared to polypoid adenomas, in line with previous observations.Keywords
This publication has 43 references indexed in Scilit:
- Distinct patterns of DNA methylation in conventional adenomas involving the right and left colonLaboratory Investigation, 2014
- Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancerNature Genetics, 2004
- TSLC1 Gene Silencing in Cervical Cancer Cell Lines and Cervical NeoplasiaJNCI: Journal of the National Cancer Institute, 2004
- The Paris endoscopic classification of superficial neoplastic lesions: esophagus, stomach, and colonGastrointestinal Endoscopy, 2003
- A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United KingdomAmerican Journal of Gastroenterology, 2003
- Secreted antagonists of the Wnt signalling pathwayJournal of Cell Science, 2003
- Quantitative Gstp1 Methylation Clearly Distinguishes Benign Prostatic Tissue And Limited Prostate AdenocarcinomaJournal of Urology, 2003
- Are there two sides to colorectal cancer?International Journal of Cancer, 2002
- A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancerNature Genetics, 2002
- Regulation of Wnt Signaling by Sox ProteinsMolecular Cell, 1999